| 000 | 01503 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516011237.0 | ||
| 264 | 0 | _c20101222 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1873-4502 | ||
| 024 | 7 |
_a10.1016/j.jcrs.2010.08.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSheehan, William | |
| 245 | 0 | 0 |
_aImplications of MHRA's reclassification of tamsulosin. _h[electronic resource] |
| 260 |
_bJournal of cataract and refractive surgery _cNov 2010 |
||
| 300 |
_a2007 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-1 Receptor Antagonists _xclassification |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCataract Extraction |
| 650 | 0 | 4 |
_aConsumer Product Safety _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 |
_aDrug Labeling _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aGovernment Agencies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntraoperative Complications |
| 650 | 0 | 4 |
_aIris Diseases _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _xdrug therapy |
| 650 | 0 | 4 |
_aPupil _xdrug effects |
| 650 | 0 | 4 |
_aSulfonamides _xclassification |
| 650 | 0 | 4 | _aTamsulosin |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aBooth, Adam | |
| 773 | 0 |
_tJournal of cataract and refractive surgery _gvol. 36 _gno. 11 _gp. 2007 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcrs.2010.08.022 _zAvailable from publisher's website |
| 999 |
_c20329970 _d20329970 |
||